BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29078262)

  • 1. Xiaochaihutang attenuates liver fibrosis by activation of Nrf2 pathway in rats.
    Li J; Hu R; Xu S; Li Y; Qin Y; Wu Q; Xiao Z
    Biomed Pharmacother; 2017 Dec; 96():847-853. PubMed ID: 29078262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xiaochaihutang Inhibits the Activation of Hepatic Stellate Cell Line T6 Through the Nrf2 Pathway.
    Hu R; Jia WY; Xu SF; Zhu ZW; Xiao Z; Yu SY; Li J
    Front Pharmacol; 2018; 9():1516. PubMed ID: 30666206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.
    Li JP; Gao Y; Chu SF; Zhang Z; Xia CY; Mou Z; Song XY; He WB; Guo XF; Chen NH
    Acta Pharmacol Sin; 2014 Aug; 35(8):1031-44. PubMed ID: 24976156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model.
    Sang L; Wang XM; Xu DY; Sang LX; Han Y; Jiang LY
    World J Gastroenterol; 2017 Dec; 23(47):8334-8344. PubMed ID: 29307993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of Action.
    Miao H; Zhang Y; Huang Z; Lu B; Ji L
    Am J Chin Med; 2019; 47(2):351-367. PubMed ID: 30871359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress.
    Shi H; Shi A; Dong L; Lu X; Wang Y; Zhao J; Dai F; Guo X
    Clin Nutr; 2016 Dec; 35(6):1366-1373. PubMed ID: 27017478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schisandrin B attenuates CCl
    Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
    Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
    Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
    Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats.
    Fayez AM; Zakaria S; Moustafa D
    Biomed Pharmacother; 2018 Sep; 105():428-433. PubMed ID: 29879626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of ethyl acetate fraction of Drynaria quercifolia against CCl
    Anuja GI; Shine VJ; Latha PG; Suja SR
    J Ethnopharmacol; 2018 Apr; 216():79-88. PubMed ID: 29174446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelargonidin ameliorates CCl
    Shi YS; Li XX; Li HT; Zhang Y
    Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
    Gu L; Tao X; Xu Y; Han X; Qi Y; Xu L; Yin L; Peng J
    Toxicol Appl Pharmacol; 2016 Feb; 292():19-29. PubMed ID: 26747300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esculin inhibits hepatic stellate cell activation and CCl
    Xu S; Chen Y; Miao J; Li Y; Liu J; Zhang J; Liang J; Chen S; Hou S
    Phytomedicine; 2024 Jun; 128():155465. PubMed ID: 38471319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asiatic acid ameliorates CCl
    Fan J; Chen Q; Wei L; Zhou X; Wang R; Zhang H
    Drug Des Devel Ther; 2018; 12():3595-3605. PubMed ID: 30464391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells ameliorate oxidative stress, inflammation, and hepatic fibrosis via Nrf2/HO-1 signaling pathway in rats.
    Khadrawy SM; Mohamed HM; Mahmoud AM
    Environ Sci Pollut Res Int; 2021 Jan; 28(2):2019-2030. PubMed ID: 32865681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of dimerumic acid on hepatic fibrosis caused from carboxymethyl-lysine (CML) by attenuating oxidative stress depends on Nrf2 activation in hepatic stellate cells (HSCs).
    Lee BH; Hsu WH; Hsu YW; Pan TM
    Food Chem Toxicol; 2013 Dec; 62():413-9. PubMed ID: 24036144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
    Yang JJ; Tao H; Huang C; Li J
    Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats.
    Clichici S; Olteanu D; Nagy AL; Oros A; Filip A; Mircea PA
    J Med Food; 2015 Mar; 18(3):290-8. PubMed ID: 25133972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid phenethyl ester inhibits liver fibrosis in rats.
    Li M; Wang XF; Shi JJ; Li YP; Yang N; Zhai S; Dang SS
    World J Gastroenterol; 2015 Apr; 21(13):3893-903. PubMed ID: 25852274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.